Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…<b>(B)</b> Combining low glucose, ketone supplementation, and HBOT resulted in a marked decrease in cell proliferation which was significant from control at all time points tested. …”

Syntaxin-4 shRNA decreases spine number and structural plasticity by Michael Patterson (96521)

Lipoprotein and albumin-depleted serum decreases colony-spreading stimulatory activity. by Yosuke Omae (230962)

Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

Bcl6 deficiency decreases expression of lipogenic genes and proteins in liver. by Christopher R. LaPensee (571785)

Combined EGCG/As decreases the viability of two types of EC, HUVEC and HBMEC. by Jee-Youn Kim (796526)

HAART decreases Viral Load and increases CD4 counts and percentages. by Pietro Presicce (144163)

FQE decreases capsule synthesis in <i>S. pneumoniae</i> D39. by Alistair J. Standish (322870)

RV-decreases IRAK-1 protein via TLR2 activation. by Benjamin L. Unger (130418)

Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced degranulation. by Jian Hao (160736)

Osteoblast number is decreased in <i>Hdac3</i>-CKO mice. by David F. Razidlo (230381)

Sox6 overexpression decreased the multi-lineage differentiation potential in NSPCs. by Shigeki Ohta (233204)

Over-expression of rhodopsin decreased the expression levels of differentiation markers in NHEKs. by Hyoung-June Kim (459814)

TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

Inhibition of AhR signaling decreases growth of prostate cancer cells. by Oliver Richmond (585233)

MMP7 expression decreases upon inhibition of PRL3 activity. by Srikanta Basu (721886)

The p.I126S mutation decreases FOXC1 DNA-binding. by Cristina Medina-Trillo (705087)

Image_5_A single amino acid substitution in the AAA-type ATPase LRD6-6 activates immune responses but decreases grain quality in rice.tif by Junjie Yin (3115497)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”

Transduction of Gsx2 decreases the capacity of OBSCs to differentiate into astrocytes and oligodendrocytes. by Héctor R. Méndez-Gómez (189198)